Medicare Enrolled

Dr. Mohammad Athari, M.D.

Neurology · Baytown, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4310 GARTH RD STE B, Baytown, TX 77521
2814272700
In practice since 2006 (19 years)
NPI: 1831101583 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Athari from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Athari? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Athari

Dr. Mohammad Athari is a neurology in Baytown, TX, with 19 years in practice. Based on federal Medicare data, Dr. Athari performed 439 Medicare services across 178 unique beneficiaries.

Between the years covered by Open Payments, Dr. Athari received a total of $14,715 from 74 pharmaceutical and/or device companies across 1034 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Athari is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 439 Medicare services$ $14,715 industry payments

Medicare Practice Summary

Medicare Utilization ↗
439
Medicare services
Bottom 46% in TX for neurology
178
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~23 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)192$64$200
Office visit, established patient (10-19 min)156$29$150
Injection of trigger points, 1-2 muscles65$36$140
Needle measurement of electrical activity in arm or leg muscles, complete study26$77$500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,715
Total received (2018-2024)
Avg $2,102/year across 7 years
Top 21% in TX for neurology
74
Companies
1,034
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,048 (95.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$668 (4.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$551
2023
$1,154
2022
$1,952
2021
$2,490
2020
$2,674
2019
$2,828
2018
$3,066

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Teva Pharmaceuticals USA, Inc.
$791
Supernus Pharmaceuticals, Inc.
$740
SK Life Science, Inc.
$686
Acorda Therapeutics, Inc
$668
Sunovion Pharmaceuticals Inc.
$664
Neurelis, Inc.
$632
Bausch Health US, LLC
$630
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$619
Amneal Pharmaceuticals LLC
$601
Eisai Inc.
$598
Lilly USA, LLC
$482
Adamas Pharmaceuticals, Inc.
$444
Avanir Pharmaceuticals, Inc.
$420
PFIZER INC.
$404
Amgen Inc.
$396
Novartis Pharmaceuticals Corporation
$375
ABBVIE INC.
$362
ACADIA Pharmaceuticals Inc
$359
AbbVie Inc.
$336
Neurocrine Biosciences, Inc.
$317
Scilex Pharmaceuticals Inc.
$313
Horizon Therapeutics plc
$308
SCILEX PHARMACEUTICALS INC.
$285
UCB, Inc.
$264
US WorldMeds, LLC
$218
EISAI INC.
$198
Biohaven Pharmaceutical Holding Company Ltd.
$158
Alexion Pharmaceuticals, Inc.
$136
LivaNova USA, Inc.
$102
Corium, LLC
$99
Biogen, Inc.
$98
GENZYME CORPORATION
$97
ARBOR PHARMACEUTICALS, INC.
$93
Upsher-Smith Laboratories LLC
$92
Catalyst Pharmaceuticals, Inc.
$88
Vertical Pharmaceuticals, LLC
$86
Endo Pharmaceuticals Inc.
$82
Assertio Therapeutics, Inc.
$78
GE HealthCare
$77
GE Healthcare
$74
EMD Serono, Inc.
$74
Impax Laboratories, Inc.
$72
Horizon Pharma plc
$72
GE HEALTHCARE
$71
Lundbeck LLC
$64
Mallinckrodt LLC
$58
AstraZeneca Pharmaceuticals LP
$53
Allergan Inc.
$50
Axsome Therapeutics, Inc.
$47
Allergan, Inc.
$45
ASSERTIO THERAPEUTICS, Inc.
$44
Currax Pharmaceuticals LLC
$41
JAZZ PHARMACEUTICALS INC.
$39
Sumitomo Pharma America, Inc.
$38
Iroko Pharmaceuticals, LLC
$36
Biohaven Pharmaceuticals, Inc.
$31
Merck Sharp & Dohme LLC
$31
Janssen Pharmaceuticals, Inc
$31
Abbott Laboratories
$30
Avion Pharmaceuticals
$30
Arbor Pharmaceuticals, Inc.
$30
BioDelivery Sciences International, Inc.
$30
Aprecia Pharmaceuticals, LLC
$29
Zyla Life Sciences
$28
Almatica Pharma LLC
$25
CATALYST PHARMACEUTICALS, INC.
$23
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$23
Banner Life Sciences, LLC
$21
Nevro Corp.
$16
IDORSIA PHARMACEUTICALS US INC
$16
Merck Sharp & Dohme Corporation
$13
AQUESTIVE THERAPEUTICS, INC.
$13
Promius Pharma LLC
$12
RedHill Biopharma Inc.
$11
Top 3 companies account for 15.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BELBUCA · BELSOMRA · BOTOX · BRILINTA · Briviact · CONTRAVE · COPAXONE · Cambia · DUEXIS · Dhivy · EMBEDA · EMGALITY · Edarbyclor · Eprontia · FARXIGA · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · GRALISE · Gralise · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LORZONE · LYRICA · MIGRANAL · Mavenclad · NAMZARIC · NAPRELAN · NASCOBAL · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nuedexta · ONFI · ONGENTYS · ONZETRA Xsail · OSMOLEX ER · Ongentys · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · RELISTOR ORAL · REYVOW · RYTARY · Rebif · SOLIRIS · SPRIX · SUNOSI · SYMPAZAN · Senza Spinal Cord Stimulation System · Spritam · Sunosi · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Talicia · UBRELVY · VALTOCO · VIVLODEX · VNS Therapy · VRAYLAR · VYEPTI · Vimpat · XARELTO · XCOPRI · XYREM · Xadago · ZEMBRACE SYMTOUCH · ZIPSOR · ZOMIG · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace SymTouch Sumatriptan Injection · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3,352 per 100 Medicare services performed
Looking for a neurology in Baytown?
Compare neurologys in the Baytown area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
59
Per 100K population
1.2
County median income
$73,104
Nearest hospital
HOUSTON METHODIST BAYTOWN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Athari is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Athari experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Athari performed 192 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Athari receive payments from pharmaceutical companies?
Yes. Dr. Athari received a total of $14,715 from 74 companies across 1,034 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Athari's costs compare to other neurologys in Baytown?
Dr. Athari's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Athari) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →